The role of human leukocyte antigen genes in the formation of abdominal aortic aneurysms

Journal of Vascular Surgery

Volumn 45, Issue 3, 2007, Pages 475-480

  Badger, Stephen A ^a   Soong, Chee V ^a   O'Donnell, Mark E ^a   Middleton, Derek ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; ARTICLE; AUTOIMMUNITY; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; FEMALE; GENE; GENE FREQUENCY; GENETIC PREDISPOSITION; HISTOCOMPATIBILITY; HUMAN; IMMUNOGENETICS; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; NORTHERN IRELAND; PHENOTYPE; RISK FACTORS;

EID: 33847153413     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.09.067     Document Type: Article

References (48)

1. Glasgov S. Pathology of large arteries. In: Abramson D.I., and Dobrin P.B. (Eds). Blood vessels and lymphatics in organ systems (1984), Academic Press, New York, NY 39-53
2. Dobrin P. Pathophysiology and pathogenesis of aortic aneurysms. Surg Clin North Am 69 (1989) 687-703
3. Schonbeck U., Sukhova G.K., Gerdes N., and Libby P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol 161 (2002) 499-506
4. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., and Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96 (1995) 2304-2310
5. Curci J.A., and Thompson R.W. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?. J Clin Invest 114 (2004) 168-171
6. Clifton M.A. Familial abdominal aortic aneurysms. Br J Surg 64 (1977) 765-766
7. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 (1997) 2843-2847
8. Jones G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
9. Bown M.J., Burton P.R., Horsburgh T., Nicholson M.L., Bell P.R., and Sayers R.D. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case-control study. J Vasc Surg 37 (2003) 999-1005
10. Armstrong P.J., Johanning J.M., Calton Jr. W.C., Delatore J.R., Franklin D.P., Han D.C., et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 35 (2002) 346-355
11. Pereira L., Lee S.Y., Gayraud B., Andrikopoulos K., Shapiro S.D., Bunton T., et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 96 (1999) 3819-3823
12. Pereira L., Andrikopoulos K., Tian J., Lee S.Y., Keene D.R., Ono R., et al. Targeting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfans syndrome. Nat Genet 17 (1997) 218-222
13. Towbin J.A., Casey B., and Belmont J. The molecular basis of vascular disorders. Am J Hum Genet 64 (1999) 678-684
14. Strauss E., Waliszewski K., Gabriel M., Zapalski S., and Pawlak A.L. Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. J Appl Genet 44 (2003) 85-93
15. Yen H.C., Lee F.Y., and Chau L.Y. Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis 135 (1997) 65-71
16. Ocana E., Bohorquez J.C., Perez-Requena J., Brieva J.A., and Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 170 (2003) 39-48
17. Koch A.E., Haines G.K., Rizzo R.J., Radsevich J.A., Pope R.M., Robinson P.G., et al. Human abdominal aortic aneurysms: immunophenotypical analysis suggesting an immune mediated process. Am J Pathol 137 (1990) 1199-1219
18. Brophy C.M., Reilly J.M., Walker Smith G.J., and Tilson M.D. The role of inflammation in non-specific abdominal aortic aneurysm disease. Ann Vasc Surg 5 (1991) 229-233
19. Beckman E.N. Plasma cells infiltrates in abdominal aortic aneurysms. Am J Clin Pathol 85 (1986) 21-24
20. Haug E.S., Skomsvoll J.F., Jacobsen G., Halvorsen T.B., Saether O.D., and Mythre H.O. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg 38 (2003) 492-497
21. Newman K.M., Jean-Claude J., Li H., Ramey W.G., and Tilson M.D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90 (1994) 224-227
22. Bodmer J.G., Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Charron D., et al. Nomenclature for factors of the 2HLA system. Tissue Antigens 46 (1995) 1-18
23. Tilson M.D., Ozsvath K.J., Hirose H., and Xia S. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm residues in the MHC class 2 locus DR B-1. Ann N Y Acad Sci 800 (1996) 208-215
24. Hirose H., Takagi M., Miyagawa N., Hashiyada H., Noguchi M., Tada S., et al. Genetic risk factor for abdominal aortic aneurysm: HLA-DR2(15), a Japanese study. J Vasc Surg 27 (1998) 500-503
25. Hirose H., and Tilson M.D. Negative genetic risk factor for abdominal aortic aneurysm: HLA-DQ3, a Japanese study. J Vasc Surg 11 (1999) 959-960
26. Williams F., Meenagh A., Maxwell P., and Middleton D. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy. Tissue Antigens 54 (1999) 59-68
27. Middleton D., Williams F., Hamill M.A., and Meenagh A. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy. Hum Immunol 61 (2000) 1285-1297
28. Williams F., Meenagh A., Single R., McNally M., Kelly P., Nelson M.P., et al. High resolution HLA-DRB1 identification of a Caucasian population. Hum Immunol 65 (2004) 66-77
29. UK Small Aneurysm Trial participants. Mortality results for randomised controlled trial of early surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352 (1998) 1649-1655
30. Numano F. Differences in clinical presentation and outcome in different countries for Takayasu arteritis. Curr Opin Rheumatol 9 (1997) 12-15
31. Numano F., Kobayashi Y., Maruyama Y., Kakuta T., Miyata T., and Kishi Y. Takayasu arteritis: Clinical characteristics and the role of genetic factors in its pathogenesis. Vasc Med 1 (1996) 227-233
32. Numano F., Ishohisa I., Maezawa H., and Sasazuki T. HLA-antigens in Takayasu disease. Am Heart J 98 (1979) 153-159
33. Numano F., Sasazuki T., Koyama T., Shimokado K., Takeda Y., Nishimura Y., et al. HLA in Buerger disease. Exp Clin Immunogenet 3 (1986) 195-200
34. Dong P.P., Kimura A., and Numaro F. HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels 7 suppl (1992) s73-s80
35. Mizuki N., Inoko H., Ishihara M., Ando I.I., Nakamura S., Nishio M., et al. A complete type patient with Behcet's disease associated with HLA B*5102. Acta Ophthalmol (Copenh) 72 (1994) 757-758
36. Kothari S.S. Aetiopathogenesis of Takatasu's arteritis and BCG vaccination: the missing link?. Med Hypotheses 43 (1995) 227-230
37. Weyand C.M., Hicok K.C., Hunder G.G., and Goronzy J.J. The HLA-DRB1 locus as a genetic component in giant cell arteritis. J Clin Inv 90 (1992) 2355-2361
38. Ozsvath K.J., Hirose H., Xia S., and Tilson M.D. Molecular mimicry in human aortic aneurysmal disease. Ann N Y Acad Sci 800 (1996) 288-293
39. Xia S., Ozsvath H., Hirose H., and Tilson M.D. Partial amino acid sequence of a novel 40 kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: aortic aneurysm-associated protein-40 (AAAP-40) [Human MAGP-3, proposed]. Biochem Biophys Res Commun 219 (1996) 36-39
40. Kobayashi R., Muzutani A., and Hidaka H. Isolation and characterisation of a 36 kDa microfibril associated glycoprotein by a newly synthesised isoquinoline-sulfonamide affinity chromatography. Biochem Biophys Res Commun 198 (1994) 1262-1266
41. Chew D.K., Knoetgen J., Xia S., Gaetz H.P., and Tilson M.D. Regional distribution in human of a novel aortic collagen-associated microfibrillar protein. Exp Mol Pathol 66 (1999) 59-65
42. Rasmussen T.E., Hallett J.W., Metzger R.L.M., Richardson D.M., Harmsen W.S., Goronzy J.J., et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg 25 (1997) 356-364
43. Rasmussen T.E., Hallett J.W., Schulte S., Harmsen W.S., O'Fallon W.M., and Weyand C.M. Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes. J Vasc Surg 34 (2001) 84-89
44. Rasmussen T.E., Hallett J.W., Tazelaar H.D., Miller V.M., Schulte S., O'Fallon W.M., et al. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J Vasc Surg 35 (2002) 988-993
45. Monux G., Serrano F.J., Vigil P., and de la Concha E.G. Role of HLA-DR in the pathogenesis of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 26 (2003) 211-214
46. Tilson M.D., Ozsvath K.J., Hirose H., and Xia S. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm resides in the MHC class II locus DR-beta-1. Ann N Y Acad Sci 800 (1996) 208-217
47. Weyand C.M., and Grononzy J.J. Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune disease. Clin Immunol Immunopathol 70 (1994) 91-98
48. Sugimoto T., Sada M., Miyanoto T., and Yao H. Genetic analysis on HLA loci in Japanese patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 26 (2003) 215-218